Whooping Cough Vaccine Provides Little Long-Term Protection

whooping cough vaccineA study published in the New England Journal of Medicine has found that protection from whooping cough wanes quickly after the final dose of the vaccine is administered to children around age seven.

Most children whose parents chose to follow the recommended schedule receive the vaccine in five doses beginning as an infant. Acellular pertussis is just one of the three vaccines contained in this DTaP series, which also includes diphtheria and tetanus.

The new results showed a dramatic drop in continuing protection from the vaccine after the final dose is administered. “The odds of acquiring pertussis increased by an average of 42% per year,” states to the study.

The report has added a new consideration in the ongoing question of why whooping cough has been on the rise in the US.

“Spotty vaccination rates are a problem in some places, like California, where whooping cough has roared backed recently. But the weakness of the current vaccine appears to be another factor in the resurgence of whooping cough,” reports NPR.

Read the NPR article: Whooping Cough Vaccine’s Protection Fades Quickly

Read the study: Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children

 

Melanie Mayo-Laakso

About

Melanie Mayo-Laakso is the Content Manager for Mothering.com. Mothering is the birthplace of natural family living and attachment parenting. We celebrate the experience of parenthood as worthy of one’s best efforts and are at once fierce advocates for children and gentle supporters of parents.